Cargando…
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
Our clinical trial supports the beneficial use of a high dose of methylprednisolone for the treatment of severe COVID-19 patients. https://bit.ly/3qvc4Kz
Autores principales: | Edalatifard, Maryam, Akhtari, Maryam, Salehi, Mohammadreza, Farhadi, Elham, Jamshidi, Ahmadreza, Mahmoudi, Mahdi, Rostamian, Abdolrahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898159/ https://www.ncbi.nlm.nih.gov/pubmed/33602862 http://dx.doi.org/10.1183/13993003.00324-2021 |
Ejemplares similares
-
Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021) -
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
por: Edalatifard, Maryam, et al.
Publicado: (2020) -
Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020) -
Reply to: Cause or consequence?
por: Bateman, Eric D., et al.
Publicado: (2022) -
Biologics may have a beneficial effect in asthma patients with COVID-19
por: Izquierdo, José L., et al.
Publicado: (2021)